Results 1 to 10 of about 17,306 (162)
Risk Factors for Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis: The Protective Potential of Salazosulfapyridine. [PDF]
Int J Rheum DisABSTRACT Objectives The aim of this study was to identify the risk factors for Pneumocystis jirovecii pneumonia (PCP) in patients with rheumatoid arthritis (RA) and to recommend appropriate disease‐modifying antirheumatic drug (DMARD) selection for those at high risk of developing PCP. Methods We conducted a retrospective review of patients with RA who
Hara Y +7 more
europepmc +2 more sources
Dihydropteroate Synthase Gene Mutations in Pneumocystis and Sulfa Resistance [PDF]
Emerging Infectious Diseases, 2004 Pneumocystis pneumonia (PCP) remains a major cause of illness and death in HIV-infected persons. Sulfa drugs, trimethoprim-sulfamethoxazole (TMP-SMX) and dapsone are mainstays of PCP treatment and prophylaxis.
Laurence Huang +6 more
doaj +4 more sources
Comparative Genomics Suggests Primary Homothallism of
mBio, 2015 Pneumocystis species are fungal parasites of mammal lungs showing host specificity. Pneumocystis jirovecii colonizes humans and causes severe pneumonia in immunosuppressed individuals.
João M. G. C. F. Almeida +4 more
doaj +3 more sources
Pneumocystis jirovecii pneumonia-Immune reconstitution inflammatory syndrome: A review of published cases. [PDF]
HIV MedAbstract Background Immune reconstitution inflammatory syndrome (IRIS) can occur in patients with HIV after commencing antiretroviral therapy. Tuberculosis–IRIS is the most common, and Pneumocystis jirovecii pneumonia (PJP)–IRIS accounts for only 2.7%–4% of IRIS cases.
Vaselli NM +3 more
europepmc +2 more sources
Pneumocystis jirovecii Pneumonia in Cancer Patients, a Lethal Yet Fully Preventable Disease: Insights From a Tertiary Cancer Center in East India. [PDF]
Asia Pac J Clin OncolAge and history of lung radiotherapy are overlooked risk factors for Pneumocystis jirovecii pneumonia (PCP) in cancer patients. Prophylaxis appeared to be fully effective. 21‐day mortality rate in the PCP group was 35.4%. Hematologic malignancy and lung cancer patients are at highest risk for mortality.
Chatterji S +6 more
europepmc +2 more sources
Axenic Long-Term Cultivation of Pneumocystis jirovecii
Journal of Fungi, 2023 Pneumocystis jirovecii, a fungus causing severe Pneumocystis pneumonia (PCP) in humans, has long been described as non-culturable. Only isolated short-term experiments with P.
Diana Riebold +9 more
doaj +1 more source
A Mathematical Model for Co-infection Dynamics of Pneumocystis Pneumonia and HIV/AIDS with Treatment [PDF]
Science Journal of Applied Mathematics and Statistics, 12(4),
48-63 (2024), 2023 The control of opportunistic infections among HIV infected individuals should be one of the major public health concerns in reducing mortality rate of individuals living with HIV/AIDS. In this study a deterministic co-infection mathematical model is employed to provide a quantification of treatment at each contagious stage against Pneumocystis ...
arxiv +1 more source
Avicenna Journal of Medicine, 2023 Pneumocystis jirovecii pneumonia is an opportunistic fungal infection that was mainly associated with pneumonia in patients with advanced human immunodeficiency virus (HIV) disease.
Atif Ibrahim +9 more
doaj +1 more source
SAGE Open Medical Case Reports, 2023 R-CHOP chemotherapy has been established as the first-line standard treatment for elderly patients diagnosed with diffuse large B-cell lymphoma. However, an increased risk of Pneumocystis jirovecii pneumonia in diffuse large B-cell lymphoma patients ...
Yan Xu +4 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2022 BackgroundPneumocystis jirovecii can result in a serious pulmonary infection, Pneumocystis jirovecii pneumonia, in immunocompetent hosts. The diagnosis of Pneumocystis jirovecii pneumonia has long been a major clinical concern, and there are limitations ...
Yangqing Zhan +8 more
doaj +1 more source